Skip to main content
. Author manuscript; available in PMC: 2012 Aug 23.
Published in final edited form as: Cancer Immunol Immunother. 2008 Jul 19;58(3):339–349. doi: 10.1007/s00262-008-0557-7

Table 2.

Validation by quantitative RT-PCR

Gene designation Groups compared Fold change (RT-PCR) Fold change (Microarray) P value*
COL9A1 Collagen, type IX, alpha 1 CS > chordoma 407.5 118 0.03
COL9A1 Collagen, type IX, alpha 1 CS > STS 1549.6 93.2 0.03
HMW-MAA CS > STS 3.87 3.87 0.03
HMW-MAA Chordoma > STS 7.7 9.5 0.009
HMW-MAA Chordoma = CS 2.0 NA** 0.14
CD24 CD24 antigen Chordoma > CS 36.3 27.3 0.01
CD24 CD24 antigen Chordoma > STS 50.6 26.5 0.009
T T, Brachyury Chordoma > CS 1072.9 228.1 0.03
T T, Brachyury Chordoma > STS 17157.3 79.7 0.03
*

P values are based on RT-PCR data for the respective groups compared;

**

NA HMW-MAA gene was not differentially expressed in chordoma and chondrosarcoma samples by microarray analysis